These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4453436)

  • 41. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

  • 42. Suppressive effect of adherent mononuclear cells from peripheral blood of patients with Hodgkin's disease on PHA responsiveness.
    Moghe MV; Advani SH; Gangal SG
    Indian J Exp Biol; 1981 Dec; 19(12):1101-6. PubMed ID: 7333645
    [No Abstract]   [Full Text] [Related]  

  • 43. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
    Kragballe K; Herlin T; Ellegaard J
    Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of phytohemmaglutinin on the lymphocyte culture in the course of certain lymphoproliferative and reticuloproliferative diseases. I. Blastic transformation].
    Rozynkowa D; Kowalewski J
    Pol Arch Med Wewn; 1969 Dec; 43(6):1570-7. PubMed ID: 5263320
    [No Abstract]   [Full Text] [Related]  

  • 45. Response of peripheral blood lymphocytes from normal, hypogammaglobulinemic and chronic lymphocytic leukemic patients.
    Rodey GE; Davis T; Quie PG
    J Immunol; 1972 Jan; 108(1):178-82. PubMed ID: 4622005
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunity disorders in malignant lymphomas].
    Stefanović S; Spuzić I; Ristić M; Pendić S; Ercegovac V
    Srp Arh Celok Lek; 1977; 105(3-4):245-52. PubMed ID: 929326
    [No Abstract]   [Full Text] [Related]  

  • 47. [Preliminary data on phytohemagglutinin-induced blastic transformation of lymph-node cells of patients with Hodgkin's disease].
    Tognella S; Mantovani G; Floris C; Del Giacco GS; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):386-9. PubMed ID: 5082521
    [No Abstract]   [Full Text] [Related]  

  • 48. Blastic transformation of lymphocytes in some proliferative diseases of the leukocytic system.
    Szewczyk Z; Kopaczynska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):781-7. PubMed ID: 5004016
    [No Abstract]   [Full Text] [Related]  

  • 49. [Serum and immunological studies in patients with lymphomas. 13. Examination of cellular immunity by specific and nonspecific stimulants].
    Giraudo Conesa LC; Braun M; Pavlovsky A; Bachmann AE
    Sangre (Barc); 1973; 18(3):305-12. PubMed ID: 4800716
    [No Abstract]   [Full Text] [Related]  

  • 50. [Blast transformation of lymphocytes in subjects with malignant lymphogranuloma stimulated with phytohemagglutinin and with polyinosinic-polycytidylic acid (Poly-I: Poly-C). Comparison of the effects].
    Casirola G; Marini G; Ippoliti G
    Minerva Med; 1971 Dec; 62(97):4834-7. PubMed ID: 5131190
    [No Abstract]   [Full Text] [Related]  

  • 51. [Phytohaemagglutinin blastic transformation in cancerous patients (author's transl)].
    Garcia-Puche JL; Muñoz E; Garrido F; Osorio C
    Sangre (Barc); 1974; 19(2):161-5. PubMed ID: 4605863
    [No Abstract]   [Full Text] [Related]  

  • 52. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
    Holm G; Björkholm M; Mellstedt H; Nilsson P
    J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Capacity of lymphocytes from persons with lymphogranulomatosis for blast transformation in vitro under the effect of phytohemagglutin].
    Slavnaia IL; Kaiumova MG
    Lab Delo; 1972; 4():208-12. PubMed ID: 4119837
    [No Abstract]   [Full Text] [Related]  

  • 54. Autoradiography of activated lymphocytes in the blood in Hodgkin's disease.
    Folb PI; Ramot B
    Isr J Med Sci; 1973 Jul; 9(7):923-5. PubMed ID: 4732929
    [No Abstract]   [Full Text] [Related]  

  • 55. Lymphocyte migration in malignant disease.
    Crowther D; Wagstaff J
    Clin Exp Immunol; 1983 Mar; 51(3):413-20. PubMed ID: 6342879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J; Levanon M; Davidsohn J; Ramot B
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 59. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Immunologic aspects of lymphogranulomatosis].
    Bogomolov EL; Vermel' AE; Dvoretskiĭ LI; Lorie IuI
    Ter Arkh; 1972 May; 44(5):10-6. PubMed ID: 4562560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.